Design Therapeutics stockholders elect Pratik Shah as Class III director, ratify EY auditor

Design Therapeutics, Inc.

Pratik Shah, Ph.D. elected as Class III director with ~42.8M votes for, ~3.5M withheld (7.7M broker non-votes).
Ernst & Young LLP ratified as independent auditor for FY2024 (53,981,806 for, 2,764 against, 2 abstentions).
Annual Meeting held June 13, 2024; 56,495,039 shares outstanding and entitled to vote as of record date.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.